NCA Lung Pathway Board (NCLPB)

North Region Health & Care Collaboration

Lung Pathway Board

The NCA Lung Cancer Pathway Board provides a collaborative forum for strategic focus and vision for lung cancer services throughout the North of Scotland Health Boards.

Lung cancer services in the North of Scotland

Lung is the most common cancer in Scotland; in 2020, there were 1032 new patients diagnosed in the North of Scotland.

There are two different types of lung cancer:

Small Cell Lung Cancer (SCLC)
Non Small Cell Lung Cancer (NSCLC)

Investigation and treatment of suspected lung cancer is undertaken at our three North cancer centres in Aberdeen, Dundee and Inverness. Lung cancer surgery is undertaken at Aberdeen Royal Infirmary or by referral to Edinburgh Royal Infirmary or the Golden Jubilee national hospital in Glasgow.

Many patients in the North of Scotland present with late stage lung cancer; earlier detection and prevention of lung cancer is important for improving survival.

The aim of this Pathway Board is to facilitate regional working between the centres, ensuring a focus on improving patient outcomes.

For more information on the symptoms, investigation and treatment of Lung cancer, please visit the NHS Inform website.

Pathway Board details

Clinical Director	Dr Richard Stretton
Terms of Reference	Published January 2019

National - Clinical Management Pathways (CMPs)

Clinical Management Pathways (CMPs) have been developed nationally by clinicians and represent clinical consensus on best standard of care for cancer patients within NHS Scotland.

The content is password protected and will be updated on a regular basis. Healthcare Professionals who would like access to the CMPs should register through this form to receive password information and essential updates regarding the content and platform.

NOTE: The password and the content of the password protected CMPs should not be shared.